Featured
-
-
Article |
Utility of cell-free DNA from bronchial washing fluid in diagnosis and genomic determination for radiology-suspected pulmonary nodules
- Xinyu Zhang
- , Zhuo Yu
- & Xin Zhang
-
Brief Communication
| Open AccessWhole-exome sequencing of long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancer
- Naomi Walsh
- , Charlotte Andrieu
- & John Crown
-
Review Article
| Open AccessCutaneous neurofibromas in the genomics era: current understanding and open questions
- Robert J. Allaway
- , Sara J. C. Gosline
- & Lu Q. Le
-
Genetics and Genomics
| Open AccessEpigenomic landscape of 5-hydroxymethylcytosine reveals its transcriptional regulation of lncRNAs in colorectal cancer
- Hanyang Hu
- , Maoguo Shu
- & Xiaohua Chen
-
-
Full Paper
| Open AccessRevisiting the transcriptional analysis of primary tumours and associated nodal metastases with enhanced biological and statistical controls: application to thyroid cancer
- M Tarabichi
- , M Saiselet
- & V Detours
-
Mini Review
| Open AccessTranslation of genomics-guided RNA-based personalised cancer vaccines: towards the bedside
- V Boisguérin
- , J C Castle
- & U Sahin
-
Genetics and Genomics
| Open AccessGenotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role
- P-L Clermont
- , L Sun
- & C D Helgason
-
Clinical Study
| Open AccessA feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?
- T S Maughan
- , A M Meade
- & R Kaplan
-
Molecular Diagnostics
| Open AccessAscites-derived pancreatic ductal adenocarcinoma primary cell cultures as a platform for personalised medicine
- T Golan
- , D Atias
- & R Berger
-
Genetics and Genomics
| Open AccessA personalised approach to prostate cancer screening based on genotyping of risk founder alleles
- C Cybulski
- , D Wokołorczyk
- & S A Narod
-
Clinical Study
| Open AccessKRAS mutation detection by high-resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer
- U Malapelle
- , C Carlomagno
- & G Troncone
-
Genetics and Genomics
| Open AccessPTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy
- M J Fidler
- , L E Morrison
- & P D Bonomi
-
Commentary
| Open AccessNew tricks with old dogs: personalised medicine and clinical trials
- J A Koziol
-
Clinical Study
| Open AccessDose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients
- A Abajo
- , J Rodriguez
- & J Garcia-Foncillas
-
Translational Therapeutics
| Open AccessActivating K-Ras mutations outwith ‘hotspot’ codons in sporadic colorectal tumours – implications for personalised cancer medicine
- G Smith
- , R Bounds
- & C R Wolf